Skip to main content

Jeff Lagasse

By Jeff Lagasse | 10:48 am | March 03, 2023
The top drug agency proposed tighter limits for online prescriptions of some medications, such as Adderall and opioids.
By Jeff Lagasse | 03:48 pm | March 02, 2023
The House Oversight Committee said PBMs are distorting the pharmaceutical market and limiting high-quality care.
By Jeff Lagasse | 11:12 am | March 02, 2023
By the end of 2021, gross margins per enrollee had returned to pre-pandemic levels in the Medicare Advantage market.
By Jeff Lagasse | 07:59 am | March 02, 2023
CEO Andrew Toy says the company is achieving "real momentum" toward profitability, and has priced its insurance plans with that in mind.
By Jeff Lagasse | 11:55 am | March 01, 2023
Patient volumes, ER visits, discharges and total revenues were down in January compared to December 2022.
By Jeff Lagasse | 03:33 pm | February 28, 2023
Apparent differences in potentially avoidable hospitalizations among MA plans may be explained by shifting inpatient care to other settings.
By Jeff Lagasse | 10:30 am | February 28, 2023
According to Optum, there's a high unmet need for treatments for Alzheimer's disease, as current treatments have lacked efficacy.
By Jeff Lagasse | 03:04 pm | February 27, 2023
The numbers are a bright spot as physicians across all specialties are still struggling with high rates of burnout.
By Jeff Lagasse | 11:29 am | February 27, 2023
The legislation mandates that HHS, MedPAC and MACPAC each conduct a report and issue recommendations on telehealth.
By Jeff Lagasse | 04:21 pm | February 24, 2023
The number of hospitals engaged in integrating patient health information into EHRs grew by 40% since 2017, found ONC.